Press release
Anal Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments
Anal cancer therapeutic pipeline analysis is expected to increase owing to increasing incidence globally, majorly in older adults. Major factors driving towards the pipeline growth for anal cancer include growing rate of sexually transmitted diseases and aging population. Additionally, increasing awareness regarding health issues among people is another major factor fueling the pipeline growth for anal cancer. According to American Cancer Society, the prevalence of anal cancer has increased with increasing older population. Around 8,200 new cases for anal cancer are estimated to be diagnosed with in 2017, in the U.S., out of which 5,250 cases are estimated to be present in women and 2,950 are estimated to be present in men. The disease affecting females more commonly as compared to the males.Explore Report at: www.psmarketresearch.com/market-analysis/anal-cancer-therapeutics-pipeline-analysis
Anal cancer is rare type of cancer which develops tumor in the anus as a result of abnormal and uncontrolled growth of cells. It is very much different from the common colon or rectal cancers. It is more prevalent among people with a weak immune system and in women and men who receive undergo intercourse. The symptoms of anal cancer include rectal bleeding, lumps around anus, pain and mucus discharge or jelly-like discharge from anus. Women can also experience vaginal dryness and lower back pain. The risk factors associated with anal cancer are human papilloma virus infection, weakened immune system, increasing age, smoking and anal lesions. It can be diagnosed by rectal examination, biopsy, CT scan, MRI scan and ultrasound scan. Anal cancer can be treated by surgery, resection, abdominoperineal resection, chemotherapy and radiotherapy.
Request for Table of Content at: www.psmarketresearch.com/market-analysis/anal-cancer-therapeutics-pipeline-analysis/toc-sample
Some of the key having a pipeline of anal cancer therapeutics include Advaxis, Inc., Amgen Inc., Atara Biotherapeutics Inc, Bayer AG, Cell Medica Ltd., Eli Lilly and Company, Genticel S.A., ISA Pharmaceuticals B.V., Merck & Co Inc, Millennium Pharmaceuticals Inc., Novartis AG, Ono Pharmaceutical Co., Ltd., Oryx GmbH & Co. KG, PDS Biotechnology Corporation, Sun Pharma Advanced Research Company Ltd., Taiwan Liposome Company, Ltd.
Browse Other Related Report at: www.psmarketresearch.com/industry-report/pharmaceuticals
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
Kundan
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com
347, 5th Ave. #1402
New York City, NY - 10016
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anal Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments here
News-ID: 524723 • Views: …
More Releases from P&S Market Research - Pharmaceuticals

Psoriasis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Paten …
The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of…

Diabetic Foot Ulcer Therapeutics Pipeline Projects Immense Growth Ahead
The study analysed that the diabetic foot ulcer pipeline comprises of approximately 27 drug candidates in different stages of development.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/diabetic-foot-ulcers-therapeutics-pipeline-analysis
Diabetic foot ulcer is a serious complication of diabetes and can be defined as the ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients. Diabetic foot ulcer is categorized into two types namely; neuropathic foot where…

Technological Advancements at Cellular and Molecular Level Strengthening the IgA …
The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis
The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the…

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
As per the findings of research, it…
More Releases for Anal
Evolving Market Trends In The Anal Fissure Treatment Industry: The Influence Of …
The Anal Fissure Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anal Fissure Treatment Market Size During the Forecast Period?
The market size for anal fissure treatment has seen robust growth in the past few years. The market size will escalate…
Anal Fistula Treatment Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Anal Fistula Treatment Market was valued at USD 624.06 Million in 2020 and is projected to reach USD 857.69 Million by 2028, growing at a CAGR of 4.06% from 2021 to 2028.
Market Overview for Anal Fistula Treatment Market
Anal Fistula Treatment Market OverviewThe global market for anal fistula treatment is witnessing significant growth driven by rising incidences of anal fistulas worldwide. Anal fistulas, characterized by abnormal channels between…
Maximizing Momentum: Visionaries and the Trans-anal Irrigation Market
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market research firm, has recently published a comprehensive report on the Trans-anal Irrigation Market. This report aims to provide a complete overview of the market, offering the latest updated information on various crucial aspects that are expected to impact Market trends and performance during the forecast period.
𝐆𝐚𝐢𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐓𝐫𝐚𝐧𝐬-𝐚𝐧𝐚𝐥 𝐈𝐫𝐫𝐢𝐠𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐩𝐨𝐫𝐭 𝐏𝐃𝐅 𝐧𝐨𝐰 @ https://growthmarketreports.com/request-sample/5230?utm=Openpr
𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐓𝐫𝐚𝐧𝐬-𝐚𝐧𝐚𝐥 𝐈𝐫𝐫𝐢𝐠𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭:
𝐁𝐲 𝐓𝐲𝐩𝐞 …
Anal Fistula Therapeutics Market Research and Forecast 2020-2026
The global anal fistula therapeutics market is estimated to grow at a CAGR of nearly 4.0% during the forecast period. Emerging medical tourism is expected to offer an opportunity for the growth of the market. Growing medical tourism has been witnessed in several countries. In Asia, India, Thailand, Singapore, Philippines, and Malaysia, are the major destinations for medical tourism. In India, some crucial factors that are contributing to the growth…
Anal Cancer Market Research, Development, Analytical Forecast to 2027
Anal cancer affects the tissues of the anus, at the end of the gastrointestinal tract. Anal cancer is a lump created by the abnormal and uncontrolled growth of cells in the anus. This type of cancer occurs in people with weakened immune systems, common among the women. It closely relates with some HPV (human papilloma virus) strains. Market for Anal cancer is growing because of growing sexually transmitted diseases, aging…
Global Anal Cancer Market Research Report- Forecast To 2027
Global Anal Cancer Information, by type (Squamous cell carcinomas, Adenocarcinomas, perianal skin cancers, Melanomas and others), by treatment (chemotherapy, radio therapy, surgery and others), by end users (hospitals, clinics, research institutes and others) - Forecast to 2027
Study Objectives of Anal Cancer Market:
• To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Anal Cancer market
• To provide insights…